GPT and cancer: Blood analysis for markers like AST, ALT, ALP (alkaline phosphatase), TIBL (total bilirubin), UREA, and CREA (creatinine) indicated no adverse effects on organ function (Table S3), suggesting minimal systemic toxicity and supporting IR808-ATIPA’s potential for CT-guided cancer therapy.